IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 19 filers reported holding IO BIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,592,698 | -48.5% | 1,127,260 | -39.3% | 0.05% | -50.5% |
Q3 2022 | $5,035,000 | -42.0% | 1,857,755 | 0.0% | 0.11% | -53.7% |
Q2 2022 | $8,676,000 | -11.9% | 1,857,755 | 0.0% | 0.23% | +7.4% |
Q1 2022 | $9,846,000 | -17.2% | 1,857,755 | 0.0% | 0.22% | +2.4% |
Q4 2021 | $11,890,000 | – | 1,857,755 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 3,015,545 | $6,936 | 0.80% |
Samsara BioCapital, LLC | 1,008,437 | $2,319,405 | 0.50% |
Novo Holdings A/S | 3,277,932 | $7,539,244 | 0.47% |
Avoro Capital Advisors LLC | 2,055,883 | $4,728,531 | 0.07% |
RA Capital Management | 1,127,260 | $2,592,698 | 0.05% |
Newtyn Management, LLC | 90,000 | $207,000 | 0.04% |
PFM Health Sciences, LP | 507,640 | $1,167,572 | 0.04% |
Psagot Value Holdings Ltd. / (Israel) | 40,846 | $94 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $304,060 | 0.01% |
Cannell Capital | 12,594 | $28,966 | 0.01% |